Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection
Clostridium difficile infection (CDI) remains a substantial burden on healthcare systems and is likely to remain so given our reliance on antimicrobial therapies to treat bacterial infections, especially in an aging population in whom multiple co-morbidities are common. Antimicrobial agents are a ke...
Main Authors: | Simon D. Baines, Mark H. Wilcox |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-6382/4/3/267 |
Similar Items
-
Antimicrobial susceptibility of Clostridium difficile isolated in Thailand
by: Papanin Putsathit, et al.
Published: (2017-06-01) -
Novel Antimicrobials for the Treatment of Clostridium difficile Infection
by: Nicola Petrosillo, et al.
Published: (2018-04-01) -
Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection
by: Yijian Chen, et al.
Published: (2017-08-01) -
Antimicrobial susceptibility and toxin production of Clostridium difficile isolated from diarrheal patients during 2012-2015
by: Piyada Wangroongsarb, et al.
Published: (2017-05-01) -
High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China
by: Jing-Wei Cheng, et al.
Published: (2018-06-01)